Muscular Dystrophy Research - Duchenne Muscular Dystrophy, Symptoms, Treatment

Muscular Dystrophy Research Today is a free monthly online journal that collates and summarizes the latest research about Muscular Dystrophy, including details on duchenne muscular dystrophy, symptoms, treatment.


Muscular Dystrophy Research Today

Home

View Latest Issue

Information About Muscular Dystrophy

Books on Muscular Dystrophy

Advertising in Research Today

View Other Research Today Publications



Volume 4 (2008), Issue 6 (June)

  1. Characteristics and outcomes of cardiomyopathy in children with Duchenne or Becker muscular dystrophy: a comparative study from the Pediatric Cardiomyopathy Registry.
    Am Heart J, 155(6): 998-1005. [Abstract] [Full-text]
  2. Solution structure of the inner DysF domain of myoferlin and implications for limb girdle muscular dystrophy type 2b.
    J Mol Biol, 379(5): 981-90. [Abstract] [Full-text]
  3. A novel SNaPshot assay to detect the mdx mutation.
    Muscle Nerve, 37(6): 731-5. [Abstract] [Full-text]
  4. Calpain 3 is a modulator of the dysferlin protein complex in skeletal muscle.
    Hum Mol Genet, 17(12): 1855-66. [Abstract] [Full-text]
  5. Follow-up of three patients with a large in-frame deletion of exons 45-55 in the Duchenne muscular dystrophy (DMD) gene.
    J Clin Neurosci, 15(7): 757-63. [Abstract] [Full-text]
  6. Real and expected delivery rates of patients with myotonic dystrophy undergoing intracytoplasmic sperm injection and preimplantation genetic diagnosis.
    Hum Reprod, 23(7): 1654-60. [Abstract] [Full-text]
  7. Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1.
    N Engl J Med, 358(25): 2688-97. [Abstract] [Full-text]
  8. Towards developing standard operating procedures for pre-clinical testing in the mdx mouse model of Duchenne muscular dystrophy.
    Neurobiol Dis, 31(1): 1-19. [Abstract] [Full-text]
  9. Hematopoietic cell transplantation provides an immune-tolerant platform for myoblast transplantation in dystrophic dogs.
    Mol Ther, 16(7): 1340-6. [Abstract] [Full-text]
  10. Two different PABPN1 expanded alleles in a Mexican population with oculopharyngeal muscular dystrophy arising from independent founder effects.
    Br J Ophthalmol, 92(7): 998-1002. [Abstract] [Full-text]
  11. Predictors of disrupted social participation in myotonic dystrophy type 1.
    Arch Phys Med Rehabil, 89(7): 1246-55. [Abstract] [Full-text]
  12. Sirtuin inhibition protects from the polyalanine muscular dystrophy protein PABPN1.
    Hum Mol Genet, 17(14): 2108-17. [Abstract] [Full-text]
Place a permanent text-link or advertisement here for just US$15.

© 2005-2008 Muscular Dystrophy Research Today. All Rights Reserved.



Muscular Dystrophy Research Today Archive:

Volume 1 (2005)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 2 (2006)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 3 (2007)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 4 (2008)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)



Muscular Dystrophy Books

Duchenne Muscular Dystrophy: Advances in Therapeutics (Neurological Disease and Therapy)

Duchenne Muscular Dystrophy: Advances in Therapeutics (Neurological Disease and Therapy)